RESUMO
MHC class I chain-related gene A (MICA) is located close to HLA-B gene and expressed in epithelial cells. The MICA gene is reported to be highly polymorphic as are the classical class I genes. To further assess the polymorphism in the MICA gene, we analyzed a total of 60 HLA-homozygous cells for the sequences spanning exons 2-6. In the analysis, four new MICA alleles were identified and six variations were recognized in exon 6. MICA*017, which was identified in three HLA-B57 homozygous cells (DBB, DEM and WIN), differed from MICA*002 in exon 3 and had a guanine deletion at the 3' end of exon 4. MICA*015 identified in an HLA-B45 homozygous cell (OMW) also had the same deletion that causes a frameshift mutation resulting in complete change of the transmembrane region and premature termination in the cytoplasmic tail; these alleles have a long hydrophobic leucine-rich region instead of the alanine repeat in the transmembrane region and terminate at the second position in the cytoplasmic domain. The frameshift deletion was found only in HLA-B45- or -B57-positive panels tested, suggesting a strong linkage disequilibrium between the deletion and B45 or B57. MICA*048, which was different in exon 5 from MICA*008, was identified in an HLA-B61 homozygous cell (TA21), while MICA*00901 identified in HLA-B51 homozygous cells (LUY and KT2) was distinguished from MICA*009 by exon 6.
Assuntos
Membrana Celular/genética , Éxons/genética , Mutação da Fase de Leitura/genética , Antígenos de Histocompatibilidade Classe I/genética , Sequências de Repetição em Tandem/genética , Sequência de Bases , Linhagem Celular , Citoplasma/genética , Frequência do Gene , Antígenos HLA-B/genética , Humanos , Leucina/química , Desequilíbrio de Ligação , Dados de Sequência Molecular , Polimorfismo Genético , Homologia de Sequência de Aminoácidos , Homologia de Sequência do Ácido NucleicoRESUMO
BACKGROUND: Gap junctions contain intercellular channels through which contacting cells communicate directly. The expression of connexin 32, a major gap junction protein in the liver, during the progression of chronic liver diseases has not yet been clarified. METHODS: Immunohistochemical staining was performed using anti-connexin 32 antibody on 6 specimens of normal human liver, 7 of chronic viral hepatitis, and 7 of liver cirrhosis. RESULTS: The number of gap junction plaques in chronic viral hepatitis and liver cirrhosis was significantly smaller than that in normal liver (10350+/-2180 and 7550+/-3040 vs 22560+/-3700 spots/mm2, p<0.01). The number of gap junction plaques tended to be lower in liver cirrhosis than in chronic viral hepatitis. CONCLUSION: These results suggest that in chronic liver diseases impaired intercellular communication between hepatocytes occurs.
Assuntos
Conexinas/metabolismo , Hepatite B Crônica/metabolismo , Hepatite C Crônica/metabolismo , Cirrose Hepática Alcoólica/metabolismo , Doença Crônica , Junções Comunicantes/metabolismo , Junções Comunicantes/patologia , Hepatite B Crônica/patologia , Hepatite C Crônica/patologia , Humanos , Técnicas Imunoenzimáticas , Fígado/metabolismo , Fígado/patologia , Cirrose Hepática Alcoólica/patologia , Proteína beta-1 de Junções ComunicantesRESUMO
Idiopathic dilated cardiomyopathy (IDC) is characterized by a thin-walled heart with systolic dysfunction of unknown etiology. Because abnormalities in genes for cytoskeletal proteins related to Z-disc function have recently been reported to cause IDC, genomic organization of the gene for nebulette, a novel actin-binding Z-disc protein, was determined and its sequence variations were searched for in Japanese patients with IDC and healthy controls. The nebulette gene consists of 28 exons, and four sequence variations leading to amino acid replacement (Gln187His, Met351Val, Asn654Lys, and Thr728Ala) were identified in the patients. These variations were also found in the healthy controls and hence they were polymorphisms and not disease-specific mutations. Frequencies of Gln187His, Met351Val, and Thr728Ala variants were similar in the patients and controls. However, the frequency of homozygotes for Lys at codon 654, a variant at a relatively conserved residue in an actinbinding motif, was significantly increased in nonfamilial IDC patients (n=106) as compared with healthy control subjects (n=331) (7.54% vs 1.21%, OR=6.25, P=0.002, 95% CI=1.92-20.29), while this association was not found in familial IDC patients (n=24). These observations suggest that the nebulette polymorphism in the actin-binding motif was a novel genetic marker of susceptibility to nonfamilial IDC.
Assuntos
Cardiomiopatia Dilatada/genética , Variação Genética , Proteínas Musculares/genética , Polimorfismo Genético , Adolescente , Adulto , Idoso , Sequência de Aminoácidos , Substituição de Aminoácidos , Povo Asiático/genética , Sequência de Bases , Proteínas de Transporte , Proteínas do Citoesqueleto , Primers do DNA , Éxons , Feminino , Frequência do Gene , Biblioteca Gênica , Humanos , Japão , Proteínas com Domínio LIM , Masculino , Proteínas dos Microfilamentos/genética , Pessoa de Meia-Idade , Dados de Sequência Molecular , Músculo Esquelético/metabolismo , Mutação de Sentido Incorreto , Miocárdio/metabolismo , Reação em Cadeia da Polimerase , RNA Mensageiro/genética , Valores de ReferênciaRESUMO
To address the active transport of neurotrophins, nerve growth factor, brain-derived neurotrophic factor, and neurotrophin-3 in the peripheral nerves, we examined the levels of proteins and messenger RNAs in the sciatic nerve of adult rats following transection, using enzyme immunoassays and reverse transcription polymerase chain reaction method, respectively. Neurotrophin-3 protein increased one day after transection only in the distal segment next to the transection site and returned to the original level two days later. This was considered to reflect accumulation of neurotrophin-3 transported from the periphery toward the neuronal cell bodies, because the neurotrophin-3 messenger RNA level was not changed in any sciatic segments during this experimental period. An increase in brain-derived neurotrophic factor protein was observed simultaneously in both the distal and proximal stumps three days after transection. Brain-derived neurotrophic factor messenger RNA was elevated in the same stumps two days after transection, suggesting that brain-derived neurotrophic factor was produced within the transected stumps. These observations demonstrate that neurotrophin-3, like nerve growth factor, is retrogradely transported in the sciatic nerve but that brain-derived neurotrophic factor is not. This suggests that neurotrophin-3 plays a role in the conveyance of trophic signals from target organs to neurons.
Assuntos
Fatores de Crescimento Neural/genética , Fatores de Crescimento Neural/metabolismo , Neurônios/fisiologia , Nervo Isquiático/fisiologia , Animais , Anticorpos , Transporte Axonal , Fator Neurotrófico Derivado do Encéfalo/genética , Fator Neurotrófico Derivado do Encéfalo/metabolismo , Regulação da Expressão Gênica , Humanos , Masculino , Fatores de Crescimento Neural/imunologia , Neurotrofina 3 , RNA Mensageiro/metabolismo , Ratos , Ratos Wistar , Proteínas Recombinantes/imunologia , Fatores de Tempo , Transcrição GênicaRESUMO
The first clinical application of biochemical modulation (BCM) of 5-fluorouracil (5-FU) was the sequential MTX/5-FU regimen proposed in 1977 by Bertino for the treatment of colorectal cancer. In Japan, sequential MTX/5-FU therapy was mainly used as a new method of treating gastric cancer, and attracted a great deal of attention because it proved effective in many cases of advanced gastric cancer that had been unresponsive to the previous chemotherapy, particularly scirrhous gastric cancer with poor prognosis. Its therapeutic efficacy varied according to histologic type, it was effective in cases of peritoneal dissemination and disseminated intravascular coagulopathy (DIC), it was associated with fewer adverse effects, and it was a multidrug chemotherapy based on a clear rationale. With sequential MTX/5-FU therapy as a starting point, fundamental studies of BCM and its clinical applications have expanded rapidly in Japan. This paper provides an outline of sequential MTX/5-FU therapy from the aspects of its mechanism of action, indications, therapeutic efficacy, relevance to adjuvant therapy, counter-measures to adverse effects, and emergence of resistance to the drugs involved. The high therapeutic efficacy of this therapy in certain histologic types is also discussed, and its combined use with other forms of BCM, as in triple BCM (LV/5-FU + CDDP/5-FU + MTX/5-FU), is introduced.
Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/farmacologia , Fluoruracila/farmacologia , Metotrexato/farmacologia , Neoplasias Gástricas/tratamento farmacológico , Animais , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , DNA/biossíntese , Esquema de Medicação , Sinergismo Farmacológico , Fluoruracila/administração & dosagem , Humanos , Metotrexato/administração & dosagem , Neoplasias Gástricas/químicaRESUMO
At present curative resection is the only radical treatment for gastric cancer, although recently developed combination chemotherapy shows increased activity in treating locally advanced and metastatic disease. Among several combination regimens, those based on biochemical modulation, such as sequential methotrexate/5-fluorouracil or low-dose CDDP/5-fluorouracil, are thought to provide increased efficacy with decreasing adverse reactions in unresectable gastric cancer. Therefore, a prospective randomized clinical trial comparing the prognosis of patients receiving adjuvant multi-agent chemotherapy with those treated only surgically should be pursued for estimation of the clinical benefit of these agents.
Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Fatores Imunológicos/uso terapêutico , Neoplasias Gástricas/tratamento farmacológico , Antineoplásicos Fitogênicos/administração & dosagem , Camptotecina/administração & dosagem , Camptotecina/análogos & derivados , Quimioterapia Adjuvante , Cisplatino/administração & dosagem , Doxorrubicina/administração & dosagem , Etoposídeo/administração & dosagem , Fluoruracila/administração & dosagem , Humanos , Irinotecano , Metotrexato/administração & dosagem , Neoplasias Gástricas/cirurgiaRESUMO
Cancer of the esophagus poses a great challenge to the surgical, medical, and radiation professions. Despite standardization of resection and reconstruction techniques, extended lymph node dissection, and advances in perioperative management, the overall prognosis of patients with esophageal cancer undergoing surgical resection has not improved. Preoperative combination chemoradiation therapy in patients with squamous cell esophageal carcinoma has recently received increasing attention, because preoperative chemoradiation therapy, consisting of the concurrent combination of 5-fluorouracil, cis-platinum and radiation, appears to increase the resection rate, the rate of pathological complete responders, and survival time after esophagectomy in patients with locally advanced tumors. Overall in the trials using preoperative concurrent chemoradiotherapy, major antitumor responses have been reported in 40% to 80% of patients, and, consistently, up to 42.1% pathologic complete responses have been seen at esophagectomy. Therefore, preoperative chemoradiation therapy can be anticipated for better prognosis of the patients with locally advanced esophageal cancer.
Assuntos
Carcinoma de Células Escamosas/radioterapia , Cisplatino/administração & dosagem , Neoplasias Esofágicas/radioterapia , Radiossensibilizantes/administração & dosagem , Carcinoma de Células Escamosas/mortalidade , Carcinoma de Células Escamosas/cirurgia , Quimioterapia Adjuvante , Terapia Combinada , Esquema de Medicação , Neoplasias Esofágicas/mortalidade , Neoplasias Esofágicas/cirurgia , Esofagectomia , Feminino , Fluoruracila/administração & dosagem , Humanos , Fatores Imunológicos/administração & dosagem , Masculino , Ensaios Clínicos Controlados Aleatórios como AssuntoRESUMO
Although herbal medicines are believed to be safe with few side effects, there are several reports on drug-induced liver injury caused by them. However, there are no reports of autoimmune hepatitis triggered by herbal medicines. We report here the case of a patient with autoimmune hepatitis that became clinically apparent after administration of Dai-saiko-to (Da-Chai-Hu-Tang), an herbal medicine that is used as a standard medicine in Japan.
Assuntos
Doenças Autoimunes/induzido quimicamente , Doença Hepática Induzida por Substâncias e Drogas/etiologia , Medicamentos de Ervas Chinesas/efeitos adversos , Doenças Autoimunes/diagnóstico , Doenças Autoimunes/tratamento farmacológico , Doença Hepática Induzida por Substâncias e Drogas/diagnóstico , Doença Hepática Induzida por Substâncias e Drogas/tratamento farmacológico , Combinação de Medicamentos , Fígado Gorduroso/complicações , Fígado Gorduroso/tratamento farmacológico , Feminino , Glucocorticoides/uso terapêutico , Hepatite Crônica/complicações , Hepatite Crônica/tratamento farmacológico , Humanos , Pessoa de Meia-Idade , Prednisolona/uso terapêuticoRESUMO
Recent reports have shown that response to interferon treatment is influenced by hepatic iron contents in patients with chronic hepatitis C. In those reports, however, hepatitis C virus (HCV) genotypes and serum HCV-RNA levels were not examined. The aim of the present study was to investigate whether hepatic iron contents influence the response to interferon in patients with chronic hepatitis C and whether HCV genotypes and serum HCV-RNA levels play a role in this relationship. Among 65 patients with chronic hepatitis C, hepatic iron contents were significantly high in patients with a history of excess drinking of alcohol (more than 80 g/day) compared to those without, and significantly low in female patients before menopause. Having excluded these patients, hepatic iron contents were significantly higher in patients with genotype 1b infection than those with genotype 2a and 2b infection. There was no significant correlation between hepatic iron contents and plasma HCV-RNA levels. Among the patients with genotype 1b infection, hepatic iron contents were significantly lower in the responders to interferon than those in the nonresponders (429 +/- 100 vs 875 +/- 110 micrograms/g liver, P < 0.05). From these results, it is concluded that response to interferon is mainly influenced by HCV genotypes, while hepatic iron contents may play an important role in response to interferon in patients with genotype 1b infection.
Assuntos
Hepacivirus/genética , Hepatite C/metabolismo , Interferon-alfa/uso terapêutico , Ferro/metabolismo , Fígado/metabolismo , Adolescente , Adulto , Consumo de Bebidas Alcoólicas/metabolismo , Biópsia por Agulha , Doença Crônica , Feminino , Genótipo , Hepatite C/terapia , Hepatite C/virologia , Humanos , Interferon alfa-2 , Fígado/patologia , Masculino , Menopausa/metabolismo , Pessoa de Meia-Idade , RNA Viral/sangue , Proteínas Recombinantes , Indução de RemissãoRESUMO
Nucleotide sequences of the hypervariable region (HVR) of the E2/NS1 gene of hepatitis C virus (HCV), which are now thought to contain epitopes for neutralizing antibodies, were compared between antibody-bound HCV and free HCV in a patient with type II cryoglobulinemia. Antibody-bound HCV was immunoprecipitated with anti-human immunoglobulins from serum of the patient. Total RNA was recovered from the pellet and the supernatant, respectively, and the envelope gene containing the HVR was amplified by the reverse transcription and nested polymerase chain reaction. The amplified cDNA was examined by the single strand conformation polymorphism (SSCP) analysis. Sequences of bands separated by SSCP analysis were determined by the dideoxy chain termination method. SSCP analyses revealed that the HCV populations were completely different between antibody-bound HCV and free HCV: antibody-bound HCV was composed of two bands and free HCV was composed of three bands. These five bands showed different mobility with each other on the SSCP gel. Sequencing of each band revealed distinct HVR sequences, differing in 1-34 nucleotides and 1-15 deduced amino acids. Three sequences of free HCV was similar with each other (1-5 nucleotide and 1-4 amino acid differences). On the other hand, two sequences of antibody-bound HCV had 5-34 nucleotide and 5-15 amino acid differences with free HCV. Thirteen amino acids in the 5' of HVR were completely identical in three sequences of free HCV, whereas there were three and seven amino acid differences in two sequences of antibody-bound HCV. These findings suggest that isolated specific epitopes for envelope antibodies exist within the HVR.(ABSTRACT TRUNCATED AT 250 WORDS)
Assuntos
Crioglobulinemia/complicações , Hepacivirus/genética , Hepatite C/virologia , Sequência de Aminoácidos , Sequência de Bases , Crioglobulinemia/virologia , Primers do DNA , DNA Viral/genética , Hepacivirus/isolamento & purificação , Hepatite C/complicações , Humanos , Dados de Sequência Molecular , Filogenia , Polimorfismo Conformacional de Fita Simples , Transcrição Gênica , Proteínas do Envelope Viral/genéticaRESUMO
The expression of connexin 32, a major gap junction protein, and E-cadherin, an intercellular adhesion molecule that is supposed to be involved in the regulation of gap junctional intercellular communications, was examined immunohistochemically in seven specimens of human hepatocellular carcinoma and surrounding non-carcinomatous tissues. We found that the number of connexin 32-positive spots per mm2 was significantly less in hepatocellular carcinoma tissues than in the surrounding non-carcinomatous cirrhotic tissues (4360 +/- 3390/mm2 vs 10,030 +/- 3690/mm2; p < 0.01). The number in the latter was also significantly less than that in normal controls (23,560 +/- 4170/mm2). E-cadherin was expressed in all non-carcinomatous hepatocytes as well as carcinomatous cells, except for one case of Edmondson's grade III hepatocellular carcinoma. These results suggest an impairment of cell-to-cell communications in human hepatocellular carcinomas.
Assuntos
Caderinas/análise , Carcinoma Hepatocelular/química , Conexinas/análise , Neoplasias Hepáticas/química , Comunicação Celular/fisiologia , Humanos , Imuno-Histoquímica , Cirrose Hepática/metabolismo , Proteína beta-1 de Junções ComunicantesRESUMO
A case of a 57-year-old farmer with a rare type of choledochal cyst (choledochocele; Alonso-Lej's type III) is described. The patient was admitted because of obstructive jaundice and acute biliary infection. Abdominal computed tomography scan showed a cystic lesion in the head of the pancreas, and endoscopic retrograde cholangiopancreatography disclosed cystic dilatation of the terminal portion of the common bile duct. It was suspected that the choledochocele could swell and compress the common bile duct, causing obstructive jaundice and acute cholangitis; therefore, it was surgically resected. We also reviewed 61 cases of choledochocele reported in Japan; the findings were similar to those reported in the English literature.
Assuntos
Cisto do Colédoco/complicações , Colestase/etiologia , Doença Aguda , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Colangite/etiologia , Cisto do Colédoco/cirurgia , Feminino , Humanos , Masculino , Pessoa de Meia-IdadeRESUMO
A series of lipid phosphoric acids, including 1-O-alkyl-2-lyso-glycerophosphoric acid, 1-O-acyl-2-lyso-glycerophosphoric acid, hexadecylpropanediolphosphoric acid, N-acyl-2-aminoethanolphosphoric acid, sphingosine phosphoric acid, and certain homologues and analogues, were synthesized and characterized by thin-layer chromatography, fast-atom bombardment mass spectrometry, and their ability to aggregate human platelets. The presence of a receptor for these lipid phosphoric acids that is distinct from the PAF receptor is strongly suggested from experiments involving a desensitization procedure, platelet-activating factor (PAF) receptor antagonists, and inhibitors of the lipid phosphoric acids. The unique features of the interaction of these lipid phosphoric acids with platelets include: (a) evidence for a separate receptor(s) for this diverse group of synthetic compounds, (b) no requirement for stereospecificity (i.e., no glycerol backbone), and (c) a structural requirement for a long-chain hydrocarbon residue covalently bound to a phosphoric acid residue. In the interaction of these compounds with the platelet, it is mandatory that extracellular Ca2+ and ADP be present for maximum biological activity. The potential involvement of a lipid phosphoric acid receptor, which could form a component of the activation pathway associated with various lysophospholipids and analogues, such as PAF, via a phospholipase D activation, is discussed.
Assuntos
Plaquetas/metabolismo , Fosfolipídeos/química , Fosfolipídeos/farmacologia , Fator de Ativação de Plaquetas/farmacologia , Agregação Plaquetária/efeitos dos fármacos , Plaquetas/efeitos dos fármacos , Humanos , Técnicas In Vitro , Indicadores e Reagentes , Estrutura Molecular , Fosfatidiletanolaminas/química , Fosfolipídeos/síntese química , Receptores de Superfície Celular/efeitos dos fármacos , Receptores de Superfície Celular/metabolismo , Espectrometria de Massas de Bombardeamento Rápido de Átomos , Relação Estrutura-AtividadeRESUMO
To determine the significance of the expression of alpha-smooth-muscle actin in the fibrotic human liver, normal and diseased livers were stained with anti-alpha-smooth-muscle-actin antibody by an immunoperoxidase method. Vitamin A-containing lipocytes were also identified by the modified Kupffer's gold chloride method. In the normal human liver, lipocytes as well as vascular smooth muscle cells expressed alpha-smooth-muscle actin. In alcoholic liver disease, there was an increase in the cells positive for alpha-smooth-muscle actin adjacent to the fibrotic areas, but the response of lipocytes to the gold chloride reaction diminished. In chronic hepatitis, the cells positive for alpha-smooth-muscle actin increased around the enlarged portal areas, and the response to the gold chloride reaction did not change appreciably. An increase in the cells positive for alpha-smooth-muscle actin was associated with the progression of hepatic fibrosis in the liver of patients with alcoholic liver disease and chronic hepatitis.
Assuntos
Actinas/análise , Biomarcadores/análise , Desmina/análise , Compostos de Ouro , Cirrose Hepática/metabolismo , Fígado/metabolismo , Ouro/análise , Humanos , Técnicas Imunoenzimáticas , Músculo Liso Vascular/metabolismo , Valores de Referência , Vitamina A/metabolismoRESUMO
Endothelin, a potent vasoactive peptide originally isolated from the vascular endothelial cells, exerts glycogenolytic and vasoconstrictive actions in the perfused rat liver. In this paper we demonstrate high-affinity binding sites for endothelin-1 (ET-1) on rat hepatocytes. Upon incubation at 37 degrees C, association of ET-1 with hepatocytes occurred in a time-dependent manner, was maximal between 3 and 6 h, and subsequently declined; at this temperature ET-1 was rapidly internalized with the internalized ligand exceeding the surface-bound ligand at all time points. The rate of association of 125I-ET-1 with hepatocytes was much slower when the binding assay was performed at 4 degrees C; sequestration of ET-1 in hepatocytes was also substantially reduced at this temperature. ET-1 was extremely potent in stimulating phosphoinositide metabolism in hepatocytes, with significant activation of this signal transduction process occurring at ET-1 concentrations as low as 0.1 pM, with an EC50 of 1 pM. The effect of ET-1 was coupled via a pertussis toxin-sensitive G-protein. Cholera toxin did not affect ET-1-mediated phosphoinositide metabolism and neither toxin influenced the association of 125I-ET-1 with hepatocytes. PAGE of hepatocyte membranes following exposure of the cells to 125I-ET-1 and cross-linking revealed labelling of three major proteins with apparent molecular masses of 32, 49 and 72 kDa. 125I-ET-1 labelling of each of these proteins was inhibited by unlabelled ET-1, whereas unlabelled ET-3 inhibited the labelling of only the 32 and 49 kDa proteins. 125I-ET-3 labelled the 49 kDa protein and this labelling was inhibited by both unlabelled ET-1 and ET-3. Each of these receptors appears to be functional, since both ET-1 and ET-3 stimulated phosphoinositide metabolism in hepatocytes. Down-regulation of ET-1 association and desensitization of ET-1-induced phosphoinositide metabolism occurred upon incubation of hepatocytes with the homologous ligand. Following down-regulation, the ET-1 receptor was restored to the surface of the hepatocyte by prolonged incubation, although the ET-1-stimulated phosphoinositide response remained inhibited even after complete recovery of the ET-1 association capability. These results demonstrate the presence of multiple high-affinity receptors for ET-1 on hepatocytes and the direct action of this peptide on hepatic parenchymal cells via the phosphoinositide signal transduction pathway.
Assuntos
Endotelinas/fisiologia , Fígado/metabolismo , Receptores de Endotelina/metabolismo , Transdução de Sinais , Animais , Ligação Competitiva , Células Cultivadas , Regulação para Baixo , Proteínas de Ligação ao GTP/metabolismo , Cinética , Ligantes , Masculino , Fosfatidilinositóis/metabolismo , Ratos , Ratos Sprague-DawleyRESUMO
A 64-year-old man was admitted due to ascites. Laboratory data showed hemoglobin 6.7 g/dl, mean corpuscular volume 82 fl, and ferritin 2,360 ng/ml. Liver biopsy showed hemochromatosis. The diagnosis of beta-thalassemia was suggested by a decreased ratio of beta/alpha-globin synthesis in vitro (0.26). Cloning of the beta-globin gene showed A-to-G mutation in the first base of the ATA box. He was confirmed to be homozygous for this specific allele by beta-gene complex analysis and analysis of Southern blot hybridization of the alpha- and beta-globin genes. His two sons were confirmed to be heterozygous for this allele.
Assuntos
Hemocromatose/etiologia , Talassemia beta/genética , Adulto , Sequência de Bases , Southern Blotting , Clonagem Molecular , DNA/análise , Ferritinas/sangue , Globinas/biossíntese , Globinas/genética , Humanos , Fígado/patologia , Masculino , Pessoa de Meia-Idade , Dados de Sequência Molecular , Linhagem , Polimorfismo de Fragmento de Restrição , Mapeamento por Restrição , Tomografia Computadorizada por Raios X , Talassemia beta/complicações , Talassemia beta/diagnósticoRESUMO
A new procedure for the preparation of human platelets consistently sensitive to platelet-activating factor (PAF) in the low nanomolar range has been developed. Key to the success of this approach was the addition of adenosine during the isolation phase, providing an excellent recovery of stable cells, and the inclusion of ADP in the aggregation assay, providing increased sensitivity to PAF. Examination of the binding profile of tritium-labeled PAF to these platelets in the presence or absence of ADP revealed significant difference in the Kd values but not in the number of specific binding sites. Other reagents having an influence on the reactivity and stability of the human platelets, as regards its interaction with PAF, are described.
Assuntos
Bioensaio/métodos , Plaquetas/efeitos dos fármacos , Ácido Cítrico , Fator de Ativação de Plaquetas/análise , Adenosina/farmacologia , Difosfato de Adenosina/farmacologia , Adulto , Bioensaio/estatística & dados numéricos , Plaquetas/metabolismo , Feminino , Fibrinogênio/farmacologia , Glucose/análogos & derivados , Humanos , Técnicas In Vitro , Masculino , Fator de Ativação de Plaquetas/metabolismo , Fator de Ativação de Plaquetas/farmacologia , Agregação Plaquetária , Reprodutibilidade dos Testes , Serotonina/metabolismoRESUMO
A 38-year-old male with pulmonary emphysema due to severely reduced serum alpha-1-antitrypsin (AAT) level (14.5 mg/dl) was found to have an inherited new AAT deficient variant Siiyama. Chest roentgenogram and CT scanning revealed advanced emphysema, and severe obstructive ventilatory impairment was observed. During the 4-year follow-up period, the annual rate of decline of FEV 1.0 showed approximately 10-fold greater than the normal decline in FEV 1.0 (-380 ml/yr). Treatment with tamoxifen in order to raise the serum AAT level only resulted in an insufficient increase. Augmentation therapy of human AAT should be considered in the future.
Assuntos
Enfisema Pulmonar/enzimologia , Deficiência de alfa 1-Antitripsina , Adulto , Variação Genética , Humanos , Masculino , Linhagem , Enfisema Pulmonar/tratamento farmacológico , Enfisema Pulmonar/genética , Tamoxifeno/uso terapêutico , alfa 1-Antitripsina/genéticaRESUMO
The presence of a-smooth muscle actin (smA)-positive cells has recently been reported in the fibrotic liver. Lipocytes have been considered to play important roles in hepatic fibrosis. However, the relation of the a-smA-positive cells and lipocytes has not been determined. The biological implication of a-smA expression remains unknown. To study these questions, we carried out double immunofluorescent staining of a-smA and desmin (a marker for lipocytes), or a-smA and collagen, and double immunohistochemical staining of a-smA and 5-bromo-2'-deoxyuridine (BrdUrd) in carbon tetrachloride-induced fibrotic rat livers. In normal and control livers, a-smA-positive cells were not seen in the lobules, whereas scattered desmin-positive cells were present. With the development of hepatic fibrosis, a-smA was expressed only in a portion of desmin-positive cells located predominantly around collagen bundles. A number of a-smA-positive cells in the lobules were labelled with BrdUrd. These results suggest phenotypic modulation in lipocytes and differentiation of lipocytes towards myofibroblast-like cells, since a-smA is expressed with desmin in myofibroblasts in scar tissue. The expression of a-smA may be related to events of the fibrotic process, such as tissue contraction or fibrogenesis per se.